Survival According to BRAF-V600 Tumor Mutations – An Analysis of 437 Patients with Primary Melanoma

The prognostic impact of BRAF-V600 tumor mutations in stage I/II melanoma patients has not yet been analyzed in detail. We investigated primary tumors of 437 patients diagnosed between 1989 and 2006 by Sanger sequencing. Mutations were detected in 38.7% of patients and were associated with age, hist...

Descripción completa

Detalles Bibliográficos
Autores principales: Meckbach, Diana, Bauer, Jürgen, Pflugfelder, Annette, Meier, Friedegund, Busch, Christian, Eigentler, Thomas K., Capper, David, von Deimling, Andreas, Mittelbronn, Michel, Perner, Sven, Ikenberg, Kristian, Hantschke, Markus, Büttner, Petra, Garbe, Claus, Weide, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901680/
https://www.ncbi.nlm.nih.gov/pubmed/24475086
http://dx.doi.org/10.1371/journal.pone.0086194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901680/
https://www.ncbi.nlm.nih.gov/pubmed/24475086
http://dx.doi.org/10.1371/journal.pone.0086194

Ejemplares similares